Gastritis cystica profunda (GCP), kansere benzer bir görünüme sahip nadir, iyi huylu bir lezyondur. Bu lezyon mide mukozasında lokalizedir ve polipoid hiperplazi veya ülsere mukozal lezyon ve midenin submukozasına yayılan mukozal bezlerin kistik dilatasyonu ile karakterizedir. GCP'nin kesin etiyolojisi ve patogenezi hala tam olarak açıklanamamıştır. Bu olgu sunumunda, üst gastrointestinal sistem endoskopi incelemesi sonrası GCP tanısı alan, proton pompa inhibitörüne dirençli üst gastrointestinal semptomları olan 70 yaşında bir kadın olguyu sunuyoruz. Nadir görülen bu benign antite, gastrik mural kitle lezyonlarının ayırıcı tanısında akılda tutulmalıdır.
teşekkürler
Gastritis cystica profunda (GCP) is an uncommon, benign lesion which looking a cancer-like lesion. This lesion is localized in gastric mucosa and characterized by polypoid hyperplasia or ulcerated mucosal lesion and cystic dilatation of the mucosal glands spreading into the submucosa of the stomach. Exact etiology and pathogenesis of GCP is still incompletely explained. In this case report we present a case of 70-year-old female with proton pump inhibitor resistant upper gastrointestinal symptoms who was diagnosed as GCP after upper gastrointestinal system endoscopy examination. This rare benign entity should be kept in mind in the differential diagnosis of gastric mural mass lesions.
Primary Language | English |
---|---|
Subjects | Health Care Administration |
Journal Section | Case Report |
Authors | |
Publication Date | October 22, 2020 |
Published in Issue | Year 2020 Volume: 3 Issue: 4 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.